SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 270 filers reported holding SAGE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $452,000 | -2.4% | 14 | 0.0% | 0.00% | – |
| Q1 2022 | $463,000 | -22.3% | 14 | 0.0% | 0.00% | – |
| Q4 2021 | $596,000 | -3.9% | 14 | 0.0% | 0.00% | – |
| Q3 2021 | $620,000 | -97.0% | 14 | -96.4% | 0.00% | -100.0% |
| Q2 2021 | $20,459,000 | -29.9% | 390 | 0.0% | 0.01% | -37.5% |
| Q1 2021 | $29,190,000 | -13.5% | 390 | 0.0% | 0.01% | -20.0% |
| Q4 2020 | $33,737,000 | +9092.6% | 390 | +6400.0% | 0.01% | – |
| Q3 2020 | $367,000 | +47.4% | 6 | 0.0% | 0.00% | – |
| Q2 2020 | $249,000 | +44.8% | 6 | 0.0% | 0.00% | – |
| Q1 2020 | $172,000 | -61.7% | 6 | 0.0% | 0.00% | – |
| Q4 2019 | $449,000 | -46.7% | 6 | 0.0% | 0.00% | – |
| Q3 2019 | $842,000 | -23.3% | 6 | 0.0% | 0.00% | – |
| Q2 2019 | $1,098,000 | +15.1% | 6 | 0.0% | 0.00% | – |
| Q1 2019 | $954,000 | +65.9% | 6 | 0.0% | 0.00% | – |
| Q4 2018 | $575,000 | -31.1% | 6 | 0.0% | 0.00% | – |
| Q3 2018 | $834,000 | -99.2% | 6 | -99.1% | 0.00% | -100.0% |
| Q2 2018 | $103,215,000 | -0.1% | 662 | 0.0% | 0.02% | -19.0% |
| Q1 2018 | $103,305,000 | – | 662 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |